Clinical Trial Update: Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization [NA]

View source ↗

Summary

A completed clinical trial evaluating short-term embolization using gelatin particles to modulate flow during Y-90 radioembolization for liver cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases

Drugs mentioned

• Gelatin particles for embolization (gelatin particles for embolization)

Snippet

Sponsor: Next Biomedical Co., Ltd. | Conditions: Liver Cancer (Primary and Metastatic) | NA | Status: COMPLETED